Advertisement

Topics

Fresenius Kabi USA, LLC Company Profile

23:29 EST 10th December 2018 | BioPortfolio

Fresenius Kabi is focused on the care of critically and chronically ill patients inside and outside the hospital. Its portfolio of products comprises a wide range of IV drugs, infusion therapies, clinical nutrition products as well as the related medical devices and blood transfusion technologies. With a corporate philosophy of “Caring for Life,” the company’s goal is to improve the patient’s quality of life. Fresenius Kabi AG is a 100 percent subsidiary of the health care group Fresenius SE & Co. KGaA. For more information, visit www.fresenius-kabi.com.


News Articles [166 Associated News Articles listed on BioPortfolio]

Fresenius Kabi launches Simplist in prefilled syringe

Positive phase I results for Fresenius Kabi’s pegfilgrastim biosimilar

Fresenius Kabi, one of the independently operated business segments of global healthcare group Fresenius, announced on 9 October 2018 that results from two phase I studies of its pegfilgrastim biosimi...

Fresenius Kabi agrees to acquire Akorn for $4.3bn

German healthcare firm Fresenius Kabi has agreed to acquire US prescription and over-the-counter (OTC) pharmaceutical products manufacturer Akorn for around $4.3bn.

Fresenius Kabi launches generic Trisenox

AbbVie Announces Resolution Of HUMIRA Patent Disputes With Fresenius Kabi

BAD HOMBURG VOR DER HOEHE (dpa-AFX) - AbbVie (ABBV) announced global resolution of all intellectual property-related litigation with Fresenius Kabi over its proposed biosimilar adalimumab product....

Fresenius Kabi launches palonosetron in prefilled syringe

Fresenius Kabi has introduced a ready-to-administer prefilled syringe version of palonosetron hydrochloride, which is indicat -More- 

AbbVie settles Humira biosimilar dispute with Fresenius Kabi

U.S. drugmaker AbbVie Inc said on Thursday it has settled a patent dispute regarding its Humira biosimilar with Fresenius Kabi Oncology Ltd and will grant the Germany-based company non-exclusive marke...

Fresenius launches Trisenox generic

Fresenius Kabi has introduced its arsenic trioxide injection 10 mg/10 mL, indicated for the induction of remission and consol -More- 

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Intralipid 20%a 20% i.v. fat emulsion in excel container [Fresenius Kabi AB]

Intralipid 20%A 20% I.V. Fat Emulsion In Excel Container

Intralipid 10%a 10% i.v. fat emulsion in excel container [Fresenius Kabi AB]

Intralipid 10%A 10% I.V. Fat Emulsion In Excel Container

Intralipid 20%a 20% i.v. fat emulsion in excel container [Fresenius Kabi AB]

Intralipid 20%A 20% I.V. Fat Emulsion In Excel Container

Intralipid [Baxter Healthcare Corporation]

Intralipid 30%

Hetastarch [Teva Parenteral Medicines, Inc]

6% Hetastarch In 0.9% Sodium Chloride Injection

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

A Cost-Effectiveness Analysis of Rabbit Antithymocyte Globulin Versus Antithymocyte Globulin-Fresenius as Induction Therapy for Patients With Kidney Transplantation From Donation After Cardiac Death in China.

Induction immunosuppression therapy is used to support optimal outcomes in kidney transplantation. This study was to assess the cost-effectiveness of rabbit antithymocyte globulin (r-ATG) versus ATG-F...

Antithymocyte globulin for graft-versus-host disease prophylaxis: an updated systematic review and meta-analysis.

Graft-versus-host disease (GVHD) remains a limiting factor for successful allogeneic hematopoietic cell transplantation (allo-HCT). Conflicting data exist on the benefit of ATG on post-transplant surv...

Impact of hemodialysis on cardiovascular system assessed by pulse wave analysis.

Valuable information about cardiovascular system can be derived from the shape of aortic pulse wave being the result of reciprocal interaction between heart and vasculature. Pressure profiles in ascen...

Clinical Trials [32 Associated Clinical Trials listed on BioPortfolio]

Enteral Nutrition and Glucose Homeostasis

Different enteral nutrition formulas are tested on their effect on glucose homeostasis in critically ill medical patients.

Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial)

The primary hypothesis constitutes that the fish-oil preparation (Omegaven) is superior to the preparation based on Soja-oil (Lipovenös)to reduce signs and symptoms in patients with activ...

Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)

The study aim is to evaluate the influence of the anti-T-lymphocyte globulin ATG-Fresenius S given pre-transplant in addition to standard GvHD prophylaxis with cyclosporine A and a short c...

The Influence of Fatty-Acids on Systemic and Subcutaneous Cytokines

This is a mono-center randomized controlled trial to be performed in the Center of Medical Research (ZMF) at Medical University Graz and is composed by one screening visit (V1) and two stu...

Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation

Paediatric patients affected by haematological malignancies and eligible to undergo HSCT from an unrelated volunteer will be stratified according to the degree of compatibility with their ...

Companies [14 Associated Companies listed on BioPortfolio]

Fresenius Kabi USA, LLC

Fresenius Kabi is focused on the care of critically and chronically ill patients inside and outside the hospital. Its portfolio of products comprises a wide range of IV drugs, inf...

Fresenius AG

Fresenius is a global health care group with products and services for dialysis, the hospital and the medical care of patients at home.The Fresenius Group consists of the following three business segm...

Fresenius Kabi AG

Fresenius Kabi is the leader in Infusion Therapy and Clinical Nutrition in Europe and in its most important countries of Latin America and Asia Pacific. In addition, we are active in the field of Tran...

Fresenius Medical Care North America

Fresenius Medical Care North America is a subsidiary of Fresenius Medical Care AG & Co. KGaA, the world's largest integrated provider of products and services for individuals unde...

Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care is the world's largest, integrated provider of products and services for individuals with chronic kidney failure, a condition that affects more than 1,400,000 individuals worldw...

More Information about "Fresenius Kabi USA, LLC" on BioPortfolio

We have published hundreds of Fresenius Kabi USA, LLC news stories on BioPortfolio along with dozens of Fresenius Kabi USA, LLC Clinical Trials and PubMed Articles about Fresenius Kabi USA, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fresenius Kabi USA, LLC Companies in our database. You can also find out about relevant Fresenius Kabi USA, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


Corporate Database Quicklinks



Searches Linking to this Company Record